Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
VYNT

Overview Financials Analysis Smart Money

Vyant Bio, Inc.

VYNT · NASDAQ

Analyze with AI

Filings2

Total reported value$41.3K

Manager	Shares	Value	Change
Frontier Wealth Management LLC	202.6K	$39.3K	0.0%
Taylor Wealth Management Partners	10.3K	$2.0K	-50.0%

SymbolVYNT

Market Cap–

IPO Date2021-04-01

CEOAndrew D.C. LaFrence CPA

Employees4

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Crown ElectroKinetics Corp.

CRKN

$0.11

+115.69%

Aimei Health Technology Co., Ltd

AFJK

$52.23

+100.81%

Athira Pharma, Inc.

ATHA

$6.72

+62.52%

Sable Offshore Corp.

SOC

$8.25

+56.25%

Zeta Network Group

ZNB

$1.02

+55.73%

Peers

CohBar, Inc.

CWBR · NASDAQ

$0.41

+0.00%

Timber Pharmaceuticals, Inc.

TMBR · AMEX

$0.3426

+0.74%

9 Meters Biopharma, Inc.

NMTRQ · OTC

$0.0001

+0.00%

NeuBase Therapeutics, Inc.

NBSE · NASDAQ

$0.378

-1.56%

Altamira Therapeutics Ltd.

CYTO · NASDAQ

$0.30

+100.00%

InVivo Therapeutics Holdings Corporation

NVIV · NASDAQ

$0.3207

-34.28%

Impel Pharmaceuticals Inc.

IMPL · NASDAQ

$0.04

-27.27%

Oncternal Therapeutics, Inc.

ONCT · NASDAQ

$0.5266

-24.12%

Cassava Sciences, Inc. Warrant

SAVAW · NASDAQ

$0.03

+0.00%

Bellicum Pharmaceuticals, Inc.

BLCM · NASDAQ

$0.0748

-6.68%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.